Search research articles
Contact Us
Filters
Showing results (551-560 of 583) with videos related to
Page
of 59
Sort By:
Annals of Surgical Oncology
|
May 25, 2023
Mapping of Lymph Node Metastasis and Efficacy Index in Thoracic Esophageal Squamous Cell Carcinoma: A Large-Scale Retrospective Analysis
Kexun Li, Xin Nie, Changding Li, et al.
Acta Pharmaceutica Sinica. B
|
November 17, 2022
A novel inhibitor of ARfl and ARv7 induces protein degradation to overcome enzalutamide resistance in advanced prostate cancer
Yan Li, Ya Chu, Guangjiang Shi, et al.
Cancer Cell
|
September 8, 2009
The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia
Lars Klemm, Cihangir Duy, Ilaria Iacobucci, et al.
Journal of Medicinal Chemistry
|
July 6, 2023
Development of Biaryl-Containing Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors for Reversing AKR1C3-Mediated Drug Resistance in Cancer Treatment
Siyu He, Xianglin Chu, Yujia Wu, et al.
Emerging Microbes & Infections
|
March 29, 2024
Rat hepatitis E virus <i>(Rocahepevirus ratti)</i> exposure in cats and dogs, Hong Kong
Estie Hon-Kiu Shun, Jianwen Situ, James Yiu-Hung Tsoi, et al.
JHEP Reports : Innovation in Hepatology
|
September 2, 2022
A small animal model of chronic hepatitis E infection using immunocompromised rats
Siddharth Sridhar, Shusheng Wu, Jianwen Situ, et al.
International Journal of Surgery (London, England)
|
May 24, 2023
Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma: an observational study
Kexun Li, Xuefeng Leng, Wenwu He, et al.
Oncotarget
|
September 18, 2015
A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway
Hong Zhao, Yuming Guo, Shu Li, et al.
Journal of Virology
|
December 9, 2025
Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC
Qi Yang, Bao Xue, Xianjie Qiu, et al.
Frontiers in Immunology
|
January 5, 2024
Peripheral T lymphocyte and immunocyte subset dynamics: markers of neoadjuvant therapy outcomes in esophageal squamous cell carcinoma
Xin Nie, Shuya He, Xinming Nie, et al.
Page
of 59
Search research articles
Search
Showing results (551-560 of 583) with videos related to
Sort By:
Page
of 59
Annals of Surgical Oncology
|
May 25, 2023
Mapping of Lymph Node Metastasis and Efficacy Index in Thoracic Esophageal Squamous Cell Carcinoma: A Large-Scale Retrospective Analysis
Kexun Li, Xin Nie, Changding Li, et al.
Acta Pharmaceutica Sinica. B
|
November 17, 2022
A novel inhibitor of ARfl and ARv7 induces protein degradation to overcome enzalutamide resistance in advanced prostate cancer
Yan Li, Ya Chu, Guangjiang Shi, et al.
Cancer Cell
|
September 8, 2009
The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia
Lars Klemm, Cihangir Duy, Ilaria Iacobucci, et al.
Journal of Medicinal Chemistry
|
July 6, 2023
Development of Biaryl-Containing Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors for Reversing AKR1C3-Mediated Drug Resistance in Cancer Treatment
Siyu He, Xianglin Chu, Yujia Wu, et al.
Emerging Microbes & Infections
|
March 29, 2024
Rat hepatitis E virus <i>(Rocahepevirus ratti)</i> exposure in cats and dogs, Hong Kong
Estie Hon-Kiu Shun, Jianwen Situ, James Yiu-Hung Tsoi, et al.
JHEP Reports : Innovation in Hepatology
|
September 2, 2022
A small animal model of chronic hepatitis E infection using immunocompromised rats
Siddharth Sridhar, Shusheng Wu, Jianwen Situ, et al.
International Journal of Surgery (London, England)
|
May 24, 2023
Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma: an observational study
Kexun Li, Xuefeng Leng, Wenwu He, et al.
Oncotarget
|
September 18, 2015
A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway
Hong Zhao, Yuming Guo, Shu Li, et al.
Journal of Virology
|
December 9, 2025
Molecular mechanism of resistance to lonafarnib conferred by mutations in the cysteine-rich region of respiratory syncytial virus fusion glycoprotein and discovery of a lonafarnib-derived antiviral PROTAC
Qi Yang, Bao Xue, Xianjie Qiu, et al.
Frontiers in Immunology
|
January 5, 2024
Peripheral T lymphocyte and immunocyte subset dynamics: markers of neoadjuvant therapy outcomes in esophageal squamous cell carcinoma
Xin Nie, Shuya He, Xinming Nie, et al.
Page
of 59